Published in J Hosp Infect on December 09, 2010
The identification and epidemiology of meticillin-resistant Staphylococcus aureus and Clostridium difficile in patient rooms and the ward environment. BMC Infect Dis (2013) 0.86
Healthcare environments and spatial variability of healthcare associated infection risk: cross-sectional surveys. PLoS One (2013) 0.81
Controlling methicillin-resistant Staphylococcus aureus (MRSA) in a hospital and the role of hydrogen peroxide decontamination: an interrupted time series analysis. BMJ Open (2014) 0.78
Optimal Decision Model for Sustainable Hospital Building Renovation-A Case Study of a Vacant School Building Converting into a Community Public Hospital. Int J Environ Res Public Health (2016) 0.75
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect (2011) 17.47
Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet (2000) 11.65
Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med (2009) 8.30
Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis. N Engl J Med (1999) 5.02
Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. J Hosp Infect (2006) 4.15
Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy. Rheumatology (Oxford) (2003) 3.70
Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect (2004) 3.69
Methicillin-resistant Staphylococcus aureus (MRSA): burden of disease and control challenges in Europe. Euro Surveill (2010) 3.15
Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis (1994) 2.67
MRSA behind bars? J Hosp Infect (2006) 2.64
Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect (2010) 2.63
Prevalence of methicillin-resistant Staphylococcus aureus among veterinarians: an international study. Clin Microbiol Infect (2007) 2.62
The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect (2003) 2.61
Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrob Agents Chemother (1998) 2.59
Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. Euro Surveill (2008) 2.43
Extracorporeal shock wave therapy for lateral epicondylitis--a double blind randomised controlled trial. J Orthop Res (2002) 2.40
Finding a benchmark for monitoring hospital cleanliness. J Hosp Infect (2010) 2.40
Ineffectiveness of topoisomerase mutations in mediating clinically significant fluoroquinolone resistance in Escherichia coli in the absence of the AcrAB efflux pump. Antimicrob Agents Chemother (2000) 2.40
Extracorporeal shock wave therapy for plantar fasciitis. A double blind randomised controlled trial. J Orthop Res (2003) 2.38
Four country healthcare associated infection prevalence survey 2006: overview of the results. J Hosp Infect (2008) 2.35
Prospective, randomised, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy. BMJ (1999) 2.28
MRSA in livestock animals-an epidemic waiting to happen? Clin Microbiol Infect (2008) 2.23
Problems of comprehensive shared diabetes care. Br Med J (Clin Res Ed) (1987) 2.20
Hospital-acquired infections related to contaminated substances. J Hosp Infect (2006) 2.20
No time for handwashing!? Handwashing versus alcoholic rub: can we afford 100% compliance? Infect Control Hosp Epidemiol (1997) 2.19
ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect (2014) 2.13
Post-discharge surveillance (PDS) for surgical site infections: a good method is more important than a long duration. Euro Surveill (2015) 2.11
VRE and meat. Lancet (1997) 2.07
First outbreak of methicillin-resistant Staphylococcus aureus ST398 in a Dutch hospital, June 2007. Euro Surveill (2008) 2.06
Hospital cleaning: problems with steam cleaning and microfibre. J Hosp Infect (2009) 2.05
Prevalence and molecular characteristics of methicillin-resistant Staphylococcus aureus (MRSA) among pigs on German farms and import of livestock-related MRSA into hospitals. Eur J Clin Microbiol Infect Dis (2009) 2.04
Revised guidelines for control of MRSA: applying appropriately-based recommendations. J Hosp Infect (1999) 2.02
Fecal carriage of vancomycin-resistant enterococci in hospitalized patients and those living in the community in The Netherlands. J Clin Microbiol (1997) 2.02
Invasive aspergillosis caused by Aspergillus ustus: case report and review. J Clin Microbiol (1999) 2.02
Staphylococcus epidermidis biofilms: importance and implications. J Med Microbiol (2001) 2.01
Infection control measures to limit the spread of Clostridium difficile. Clin Microbiol Infect (2008) 2.01
Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants Selected with a fluoroquinolone. Antimicrob Agents Chemother (2001) 1.93
Probable transmission of HIV from an orthopedic surgeon to a patient in France. Ann Intern Med (1999) 1.92
Microbiological tests to predict treatment outcome in experimental device-related infections due to Staphylococcus aureus. J Antimicrob Chemother (1994) 1.89
SurvNet@RKI--a multistate electronic reporting system for communicable diseases. Euro Surveill (2006) 1.79
Molecular typing of methicillin-resistant Staphylococcus aureus: can PCR replace pulsed-field gel electrophoresis? J Clin Microbiol (2003) 1.79
Systematic literature analysis and review of targeted preventive measures to limit healthcare-associated infections by meticillin-resistant Staphylococcus aureus. Euro Surveill (2014) 1.79
Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection. Clin Infect Dis (2012) 1.79
Nosocomial and community-acquired infections in Germany. Summary of the results of the First National Prevalence Study (NIDEP) Infection (1997) 1.78
Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection (2003) 1.77
Incidence and risk factors for community-acquired acute gastroenteritis in north-west Germany in 2004. Eur J Clin Microbiol Infect Dis (2009) 1.76
Development and evaluation of a PCR-based immunoassay for the rapid detection of methicillin-resistant Staphylococcus aureus. J Med Microbiol (1998) 1.76
Syndromic surveillance based on emergency department activity and crude mortality: two examples. Euro Surveill (2006) 1.73
Extracorporeal shock-wave therapy for tendonitis of the rotator cuff. A double-blind, randomised, controlled trial. J Bone Joint Surg Br (2002) 1.71
Automatic alerts for methicillin-resistant Staphylococcus aureus surveillance and control: role of a hospital information system. Infect Control Hosp Epidemiol (1996) 1.71
Prevalence of livestock-associated MRSA in broiler flocks and risk factors for slaughterhouse personnel in The Netherlands. Epidemiol Infect (2010) 1.67
Ciprofloxacin-resistant Staphylococcus aureus. Lancet (1985) 1.67
Trends in antibiotic use at a university hospital: defined or prescribed daily doses? Patient days or admissions as denominator? Infection (2006) 1.66
Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet (2000) 1.61
Microbial monitoring of the hospital environment: why and how? J Hosp Infect (2012) 1.60
National hand hygiene campaigns in Europe, 2000-2009. Euro Surveill (2009) 1.58
Trial of oral miltefosine for visceral leishmaniasis. Lancet (1998) 1.58
Optimized symbolic dynamics approach for the analysis of the respiratory pattern. IEEE Trans Biomed Eng (2005) 1.57
The contribution of beds to healthcare-associated infection: the importance of adequate decontamination. J Hosp Infect (2008) 1.56
Cleanliness audit of clinical surfaces and equipment: who cleans what? J Hosp Infect (2011) 1.56
Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe. Euro Surveill (2007) 1.55
Usefulness of culture in the diagnosis of Clostridium difficile infection. Eur J Clin Microbiol Infect Dis (1995) 1.54
Experience and lessons from surveillance and studies of the 2009 pandemic in Europe. Public Health (2010) 1.54
Is it really clean? An evaluation of the efficacy of four methods for determining hospital cleanliness. J Hosp Infect (2009) 1.53
Three-year prevalence of healthcare-associated infections in Dutch nursing homes. J Hosp Infect (2011) 1.52
Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia. Ann Hematol (1994) 1.51
In vivo verification of in vitro model of antibiotic treatment of device-related infection. Antimicrob Agents Chemother (1995) 1.50
Public reporting of healthcare-associated infection data in Europe. What are the views of infection prevention opinion leaders? J Hosp Infect (2012) 1.49
Effectiveness of a new decolonisation regimen for eradication of extended-spectrum β-lactamase-producing Enterobacteriaceae. J Hosp Infect (2010) 1.49
Educating healthcare workers to optimal hand hygiene practices: addressing the need. Infection (2010) 1.49
Comparison of pulsed-field gel electrophoresis with isoenzyme profiles as a typing system for Candida tropicalis. Clin Infect Dis (1993) 1.49
gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli. J Antimicrob Chemother (1996) 1.48
Use of multistate models to assess prolongation of intensive care unit stay due to nosocomial infection. Infect Control Hosp Epidemiol (2006) 1.47
Association of organic solvent tolerance and fluoroquinolone resistance in clinical isolates of Escherichia coli. J Antimicrob Chemother (1998) 1.47
Early detection of aspergillus infection after allogeneic stem cell transplantation by polymerase chain reaction screening. J Infect Dis (2000) 1.47
What techniques for diagnosis of ventilator-associated pneumonia? Lancet (1998) 1.45
The genetics of staphylococcal biofilm formation--will a greater understanding of pathogenesis lead to better management of device-related infection? Clin Microbiol Infect (2005) 1.45
SARS: retrospective cohort study among German guests of the Hotel 'M', Hong Kong. Euro Surveill (2003) 1.45
First wave of the influenza A/H1N1v pandemic in Switzerland. Swiss Med Wkly (2009) 1.45
A European perspective on nosocomial urinary tract infections I. Report on the microbiology workload, etiology and antimicrobial susceptibility (ESGNI-003 study). European Study Group on Nosocomial Infections. Clin Microbiol Infect (2001) 1.45
Pyogenic bacterial pneumonia in human immunodeficiency virus-infected inpatients: a clinical, radiological, microbiological, and epidemiological study. Clin Infect Dis (1998) 1.44
The practice of perioperative antibiotic prophylaxis in eight German hospitals. Infection (2002) 1.44
Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study. AIDS (1999) 1.44
Behavioural considerations for hand hygiene practices: the basic building blocks. J Hosp Infect (2006) 1.43
Risk groups for clinical complications of norovirus infections: an outbreak investigation. Clin Microbiol Infect (2006) 1.41
[Prevalence of methicillin-resistant Staphylococcus aureus (MRSA) in patients in long-term care in hospitals, rehabilitation centers and nursing homes of a rural district in Germany]. Dtsch Med Wochenschr (2008) 1.41
Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin Infect Dis (2001) 1.41
A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). European Study Group on Nosocomial Infection. Clin Microbiol Infect (2001) 1.40
[Scabies outbreak in a hospital and in 8 health-care institutions caused by an elderly patient with scabies crustosa]. Ned Tijdschr Geneeskd (2006) 1.39
Why isolate theatre suites? Lancet (1991) 1.39
Prevalence of vancomycin-resistant enterococci in Europe. Eur J Clin Microbiol Infect Dis (2000) 1.39
The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect (2012) 1.39
Theatre air and operating conditions. J Hosp Infect (1995) 1.38
Needleless intravenous systems. Infect Control Hosp Epidemiol (1997) 1.38
On the wrong scent: banning fresh flowers from hospitals. J Hosp Infect (2006) 1.38
Therapeutic drug monitoring of vancomycin in patients receiving haemodialysis: time for a change. J Clin Pathol (2006) 1.38